Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE

Autor: Eric P. Krenning, Philippe Ruszniewski, David L. Bushnell, Andrew Eugene Hendifar, Oscar Leeuwenkamp, Paola Santoro, Beth R Chasen, Edward M. Wolin, Per Broberg, Matthew H. Kulke, Ghassan El-Haddad, Kjell Öberg, Martyn Caplin, Jonathan R. Strosberg, Richard P. Baum, Rajaventhan Srirajaskanthan

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 62, iss 12
Journal of Nuclear Medicine, 62(12), 1712-1718. Society of Nuclear Medicine and Molecular Imaging

We report the impact of 177Lu-DOTATATE treatment on abdominal pain, diarrhea, and flushing, symptoms that patients with advanced midgut neuroendocrine tumors often find burdensome. Methods: All patients enrolled in the international randomized phase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e3c2d6cd0409f21dbd06f05d21eaff1
https://doi.org/10.2967/jnumed.120.258897

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.

Autor: Singh, Simron, Hope, Thomas A, Bergsland, Emily B, Bodei, Lisa, Bushnell, David L, Chan, Jennifer A, Chasen, Beth R, Chauhan, Aman, Das, Satya, Dasari, Arvind, Rivero, Jaydira Del, El-Haddad, Ghassan, Goodman, Karyn A, Halperin, Daniel M, Lewis, Mark A, Lindwasser, O Wolf, Myrehaug, Sten, Raj, Nitya P, Reidy-Lagunes, Diane L, Soares, Heloisa P

Publikováno v: JNCI: Journal of the National Cancer Institute; Sep2023, Vol. 115 Issue 9, p1001-1010, 10p